Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIRNAOMICS-B

9.230
-0.540-5.53%
Volume:250.85K
Turnover:2.35M
Market Cap:978.38M
PE:-1.79
High:9.840
Open:9.480
Low:9.100
Close:9.770
52wk High:22.780
52wk Low:2.350
Shares:106.00M
HK Float Shares:106.00M
Volume Ratio:0.43
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-5.156
ROE:-1188.81%
ROA:-39.84%
PB:-24.59
PE(LYR):-1.79
PS:132.62

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
SIRNAOMICS-B
Exchange:
SEHK
Establishment Date:
2007
Employees:
52
Office Location:
Hopewell Centre,46th Floor,183 Queen’s Road East,Wan Chai,Hong Kong
Website:
https://www.sirnaomics.com/en/
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Sirnaomics Ltd. is an investment holding company. The Company and its subsidiaries are clinical-stage biotechnology companies that are engaged in developing and commercializing ribonucleic acid interference (RNAi) technology and multiple therapeutics. The Company is engaged in discovering and developing drugs for indications with unmet medical needs in areas. Its lead clinical drug candidates include STP705 and STP707. Its STP705 is a sterile drug product for the treatment of nonmelanoma skin cancer (NMSC), including squamous cell carcinoma in situ and basal cell carcinoma (BCC), recurrent keloids after keloidectomy, hypertrophic scar (HTS) and solid liver tumors, as well as for medical aesthetics. Its STP707 is a sterile drug product for the treatment of solid tumors, including liver cancer, metastatic cutaneous squamous-cell skin cancer (cSCC) and non-small cell lung cancer. It is capitalizing on its dual delivery platforms, which include Polypeptide nanoparticle (PNP) and GalAhead.

Directors

Name
Position
HUANG Meng Ying
Chairman of the Board,Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
PAN Hong Hui
Chairman of the Board,Executive Director,Member of the Nomination Committee
WANG Yu Shan
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Chairman,调查委员会委员
ZHANG Peng
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,调查委员会委员
LO Yee Hang
Independent Director,Chairman of the Nomination Committee,Audit Committee Member,调查委员会主席
OU Yang Yun Long
Director,Member of the Remuneration and Assessment Committee,Audit Committee Member
YAN Hui Jun
Director

Shareholders

Name
Position
PAN Hong Hui
CEO
YUAN Run Ting
Corporate Secretary
XIE Yong Ji
Other Senior Executives
Wang Edward Yongxiang
Other Senior Executives